Publications

Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer’s disease

 153
Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer’s disease

Tags:

Previous Article

A small-molecule to treat Alzheimer’s disease

Next Article

Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity

Related Posts

Dual regulation of IP3 receptors by IP3 and PIP2 controls the transition from local to global Ca2+ signals

Dual regulation of IP3 receptors by IP3 and PIP2 contro...

 119

CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation

CaMKII monomers are sufficient for GluN2B binding, co-c...

 47

Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma

Targeting TFAP2β condensation suppresses the developmen...

 89